Selective Deuteration Improves the Affinity of Adenosine A 2A Receptor Ligands: A Computational Case Study with Istradefylline and Caffeine
Journal of Chemical Information and Modeling · 2023
DOI: 10.1021/acs.jcim.3c00424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2023. Verfasst von Lucija Hok und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for the Computational Design and Synthesis of Functional Materials, Division of Organic Chemistry and Biochemistry, Ruđer Bošković Institu…. Hauptthemen laut MEDLINE: Caffeine, Receptor, Adenosine A2A. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: European Commission, Hrvatska Zaklada za Znanost, Croatian Government.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory for the Computational Design and Synthesis of Functional Materials, Division of Organic Chemistry and Biochemistry, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
ORCID-Profile: Robert Vianello
Förderung
- European Commission
- Hrvatska Zaklada za Znanost
- Croatian Government
Zitieren
APA
Hok, L., & Vianello, R. (2023). Selective Deuteration Improves the Affinity of Adenosine A 2A Receptor Ligands: A Computational Case Study with Istradefylline and Caffeine. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.3c00424
Vancouver
Hok L, Vianello R. Selective Deuteration Improves the Affinity of Adenosine A 2A Receptor Ligands: A Computational Case Study with Istradefylline and Caffeine. Journal of Chemical Information and Modeling. 2023. doi:10.1021/acs.jcim.3c00424
BibTeX
@article{Hok2023,
author = {Hok, Lucija and Vianello, Robert},
title = {Selective Deuteration Improves the Affinity of Adenosine A 2A Receptor Ligands: A Computational Case Study with Istradefylline and Caffeine},
journal = {Journal of Chemical Information and Modeling},
year = {2023},
doi = {10.1021/acs.jcim.3c00424}
}
EUVIMED